EML4 and non-small cell lung carcinoma: This is of particular relevance for ALK rearranged NSCLC, as the EML4-ALK gene fusion has been demonstrated previously to cause an immunosuppressive TME through activation of downstream signaling pathways such as PI3K, MAPK and Hippo pathways [40,41].